Panther Fusion® System

Flexibility, capacity and expanded menu plus the ability to run laboratory developed tests

Add on the power to run real-time PCR, TMA and RT-TMA assays on a single, fully automated platform. With the Panther Fusion® module you can consolidate testing, increase walkaway time and enhance flexibility.

  Labor savings

• Up to 32 assay reagent kits on board, which allow assay consolidation on a single platform

• Ready-to-use reagent cartridges reduce manual preparation and operator errors

• Sample throughput up to 500 tests in 8 hours increases test volume in a shift without increasing staff

• Minimal hardware/software changes allow additional testing without extensive retraining or SOP updates

  Time savings

• Open Access™ functionality provides full automation to run laboratory developed tests with IVDs

• Time-to-first result at 2.4 hours allows patient results to be released sooner and improves turnaround time

• Add on additional IVD menu without disrupting existing workflow

  Cost savings

• Run up to 5 PCR reactions from a single (360μL) patient extraction, reducing extraction time and costs

• 60-day onboard stability of reagents and fluids minimizes reagent waste for better cost management

• Utilize existing Panther® system LIS connection for Panther Fusion® assays, reducing LIS costs

• In-lab upgrade increases test volumes, throughput and menu without replacing equipment or infrastructure

Consolidate your assay menu

The Aptima® and Panther Fusion assays help guide patient care and enable early detection. With a menu and pipeline of world-class assays you can consolidate your molecular testing today and meet your lab’s growing needs tomorrow.

	Women's Health	Infectious Disease
	CT/NG	HIV-1 Quant
	Mycoplasma genitalium	HIV-1 Qual Claim† ‡
	Trichomonas vaginalis	HCV
	Bacterial vaginosis	HBV
	Candida vaginitis/Trichomonas vaginalis	CMV†
	HSV 1 & 2	Flu A/B/RSV
	HPV	Paraflu
	HPV 16 18/24	AdV/hMPV/RV
	Group B Strep	Bordetella†
	Zika Virus*	GI Panel†

*Aptima Zika Virus assay:

This test has not been FDA cleared or approved;

This test has been authorized by FDA under an EUA for use by authorized laboratories;

This test has been authorized only for the detection of RNA from Zika virus and diagnosis of Zika virus infection, not for any other viruses or pathogens; and

This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of the emergency use of in vitro diagnostic tests for detection of Zika virus and/or diagnosis of Zika virus infection under section 564(b)(1) of the Act, 21 U.S.C.§ 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.

† In Development and not for sale

‡ Seeking dual claim for the HIV-1 Quant assay.